BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 35869095)

  • 1. Structure of DNMT3B homo-oligomer reveals vulnerability to impairment by ICF mutations.
    Gao L; Guo Y; Biswal M; Lu J; Yin J; Fang J; Chen X; Shao Z; Huang M; Wang Y; Wang GG; Song J
    Nat Commun; 2022 Jul; 13(1):4249. PubMed ID: 35869095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNMT3B PWWP mutations cause hypermethylation of heterochromatin.
    Taglini F; Kafetzopoulos I; Rolls W; Musialik KI; Lee HY; Zhang Y; Marenda M; Kerr L; Finan H; Rubio-Ramon C; Gautier P; Wapenaar H; Kumar D; Davidson-Smith H; Wills J; Murphy LC; Wheeler A; Wilson MD; Sproul D
    EMBO Rep; 2024 Mar; 25(3):1130-1155. PubMed ID: 38291337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA replication is altered in Immunodeficiency Centromeric instability Facial anomalies (ICF) cells carrying DNMT3B mutations.
    Lana E; Mégarbané A; Tourrière H; Sarda P; Lefranc G; Claustres M; De Sario A
    Eur J Hum Genet; 2012 Oct; 20(10):1044-50. PubMed ID: 22378288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The DNMT3B DNA methyltransferase gene is mutated in the ICF immunodeficiency syndrome.
    Hansen RS; Wijmenga C; Luo P; Stanek AM; Canfield TK; Weemaes CM; Gartler SM
    Proc Natl Acad Sci U S A; 1999 Dec; 96(25):14412-7. PubMed ID: 10588719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defective de novo methylation of viral and cellular DNA sequences in ICF syndrome cells.
    Tao Q; Huang H; Geiman TM; Lim CY; Fu L; Qiu GH; Robertson KD
    Hum Mol Genet; 2002 Sep; 11(18):2091-102. PubMed ID: 12189161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural basis of ICF-causing mutations in the methyltransferase domain of DNMT3B.
    Lappalainen I; Vihinen M
    Protein Eng; 2002 Dec; 15(12):1005-14. PubMed ID: 12601140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA methyltransferase 3B (DNMT3B) mutations in ICF syndrome lead to altered epigenetic modifications and aberrant expression of genes regulating development, neurogenesis and immune function.
    Jin B; Tao Q; Peng J; Soo HM; Wu W; Ying J; Fields CR; Delmas AL; Liu X; Qiu J; Robertson KD
    Hum Mol Genet; 2008 Mar; 17(5):690-709. PubMed ID: 18029387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expanding the mutation spectrum in ICF syndrome: Evidence for a gender bias in ICF2.
    van den Boogaard ML; Thijssen PE; Aytekin C; Licciardi F; Kıykım AA; Spossito L; Dalm VASH; Driessen GJ; Kersseboom R; de Vries F; van Ostaijen-Ten Dam MM; Ikinciogullari A; Dogu F; Oleastro M; Bailardo E; Daxinger L; Nain E; Baris S; van Tol MJD; Weemaes C; van der Maarel SM
    Clin Genet; 2017 Oct; 92(4):380-387. PubMed ID: 28128455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations in DNA methyltransferase DNMT3B in ICF syndrome affect its regulation by DNMT3L.
    Xie ZH; Huang YN; Chen ZX; Riggs AD; Ding JP; Gowher H; Jeltsch A; Sasaki H; Hata K; Xu GL
    Hum Mol Genet; 2006 May; 15(9):1375-85. PubMed ID: 16543361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNMT3b protects centromere integrity by restricting R-loop-mediated DNA damage.
    Shih HT; Chen WY; Wang HY; Chao T; Huang HD; Chou CH; Chang ZF
    Cell Death Dis; 2022 Jun; 13(6):546. PubMed ID: 35688824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subtelomeric methylation distinguishes between subtypes of Immunodeficiency, Centromeric instability and Facial anomalies syndrome.
    Toubiana S; Velasco G; Chityat A; Kaindl AM; Hershtig N; Tzur-Gilat A; Francastel C; Selig S
    Hum Mol Genet; 2018 Oct; 27(20):3568-3581. PubMed ID: 30010917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive structure-function characterization of DNMT3B and DNMT3A reveals distinctive de novo DNA methylation mechanisms.
    Gao L; Emperle M; Guo Y; Grimm SA; Ren W; Adam S; Uryu H; Zhang ZM; Chen D; Yin J; Dukatz M; Anteneh H; Jurkowska RZ; Lu J; Wang Y; Bashtrykov P; Wade PA; Wang GG; Jeltsch A; Song J
    Nat Commun; 2020 Jul; 11(1):3355. PubMed ID: 32620778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ICF syndrome mutations cause a broad spectrum of biochemical defects in DNMT3B-mediated de novo DNA methylation.
    Moarefi AH; Chédin F
    J Mol Biol; 2011 Jun; 409(5):758-72. PubMed ID: 21549127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA methyltransferase 3B mutations linked to the ICF syndrome cause dysregulation of lymphogenesis genes.
    Ehrlich M; Buchanan KL; Tsien F; Jiang G; Sun B; Uicker W; Weemaes CM; Smeets D; Sperling K; Belohradsky BH; Tommerup N; Misek DE; Rouillard JM; Kuick R; Hanash SM
    Hum Mol Genet; 2001 Dec; 10(25):2917-31. PubMed ID: 11741835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Novel Mutation in a Critical Region for the Methyl Donor Binding in DNMT3B Causes Immunodeficiency, Centromeric Instability, and Facial Anomalies Syndrome (ICF).
    Rechavi E; Lev A; Eyal E; Barel O; Kol N; Barhom SF; Pode-Shakked B; Anikster Y; Somech R; Simon AJ
    J Clin Immunol; 2016 Nov; 36(8):801-809. PubMed ID: 27734333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HELLS and CDCA7 comprise a bipartite nucleosome remodeling complex defective in ICF syndrome.
    Jenness C; Giunta S; Müller MM; Kimura H; Muir TW; Funabiki H
    Proc Natl Acad Sci U S A; 2018 Jan; 115(5):E876-E885. PubMed ID: 29339483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Roles for Dnmt3b in mammalian development: a mouse model for the ICF syndrome.
    Ueda Y; Okano M; Williams C; Chen T; Georgopoulos K; Li E
    Development; 2006 Mar; 133(6):1183-92. PubMed ID: 16501171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunodeficiency, centromeric region instability, facial anomalies syndrome (ICF).
    Ehrlich M; Jackson K; Weemaes C
    Orphanet J Rare Dis; 2006 Mar; 1():2. PubMed ID: 16722602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ICF1-Syndrome-Associated
    Verma A; Poondi Krishnan V; Cecere F; D'Angelo E; Lullo V; Strazzullo M; Selig S; Angelini C; Matarazzo MR; Riccio A
    Biomolecules; 2023 Nov; 13(12):. PubMed ID: 38136588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-random length distribution of individual telomeres in immunodeficiency, centromeric instability and facial anomalies syndrome, type I.
    Sagie S; Edni O; Weinberg J; Toubiana S; Kozlovski T; Frostig T; Katzin N; Bar-Am I; Selig S
    Hum Mol Genet; 2017 Nov; 26(21):4244-4256. PubMed ID: 28973513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.